IMDZ

IMMUNE DESIGN CORP.CIK 1437786 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for IMDZ PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for IMDZ

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Ponoi Management, LLC	10% Owner	1	$0	$0	2019-04-02
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	24	$0	$11.2K	2019-04-02
Paya Carlos V	President and CEO	37	$0	$74.9K	2019-04-02
Brady Stephen R	EVP, Strategy & Finance	39	$10.3K	$31.4K	2019-04-02
ter Meulen Jan Henrik	Chief Scientific Officer	29	$0	$19.0K	2019-04-02
Gombotz Wayne	Chief Development Officer	36	$0	$308.8K	2019-04-02
Kelley Susan L.	Director	7	$0	$0	2019-04-02
BERGER FRANKLIN M	Director	14	$1.48M	$327.5K	2019-04-02
RINGO WILLIAM R	Director	8	$0	$0	2019-04-02
COLEMAN LEWIS W	Director	20	$1.23M	$62.0K	2019-04-02
PENHOET EDWARD	Director, 10% Owner	21	$3.59M	$0	2019-04-02
BALTIMORE DAVID	Director	11	$0	$0	2019-04-02
Biotechnology Value Trading Fund OS LP	Other	3	$0	$1.65M	2018-12-04
GUTHART LEO	10% Owner	16	$10.70M	$0	2018-01-08
Svennilson Peter	Director, 10% Owner	17	$20.78M	$0	2018-01-04
GOEDDEL DAVID V	10% Owner	12	$15.78M	$0	2017-10-27
Column Group II GP, LP	10% Owner	1	$5.00M	$0	2016-09-20
Kenney Richard T	Chief Medical Officer	4	$0	$0	2016-01-04
ATWOOD BRIAN G	Director, 10% Owner	14	$2.80M	$2.50M	2016-01-04
Moorin Jay	10% Owner	11	$0	$6.36M	2015-05-12
ProQuest Investments IV, L.P.	10% Owner	19	$0	$5.15M	2015-04-24
SCHREIBER ALAIN	10% Owner	7	$0	$4.75M	2015-04-16
ProQuest Associates IV LLC	10% Owner	13	$4.69M	$4.15M	2015-04-01
Rickey James Paul	VP, Finance and Administration	1	$0	$0	2015-01-07
Versant Venture Capital III, L.P.	10% Owner	12	$2.80M	$2.50M	2014-07-29
Alta Partners Management VIII, LLC	10% Owner	11	$3.59M	$0	2014-07-29

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
COLEMAN LEWIS W	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
COLEMAN LEWIS W	Director	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
COLEMAN LEWIS W	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
PENHOET EDWARD	Director	D To issuer deriv	2019-04-02	2019-04-04	3,058	—	$0	0	SEC↗
PENHOET EDWARD	Director	D To issuer deriv	2019-04-02	2019-04-04	4,281	—	$0	0	SEC↗
PENHOET EDWARD	Director	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
PENHOET EDWARD	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
PENHOET EDWARD	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
Kelley Susan L.	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
Kelley Susan L.	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
Kelley Susan L.	Director	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2019-04-02	2019-04-04	120,000	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2019-04-02	2019-04-04	69,362	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2019-04-02	2019-04-04	98,837	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2019-04-02	2019-04-04	70,000	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2019-04-02	2019-04-04	90,000	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2019-04-02	2019-04-04	46,788	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	195,289	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	67,277	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	61,161	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	244,648	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	175,000	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	216,500	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	263,009	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	293,000	—	$0	0	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2019-04-02	2019-04-04	121,000	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2019-04-02	2019-04-04	40,697	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2019-04-02	2019-04-04	6,116	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2019-04-02	2019-04-04	38,715	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2019-04-02	2019-04-04	11,407	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2019-04-02	2019-04-04	32,083	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2019-04-02	2019-04-04	120,000	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2019-04-02	2019-04-04	184,364	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2019-04-02	2019-04-04	100,000	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2019-04-02	2019-04-04	116,819	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2019-04-02	2019-04-04	79,536	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2019-04-02	2019-04-04	113,335	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2019-04-02	2019-04-04	72,620	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2019-04-02	2019-04-04	110,000	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2019-04-02	2019-04-04	110,000	—	$0	0	SEC↗
BALTIMORE DAVID	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
BALTIMORE DAVID	Director	D To issuer deriv	2019-04-02	2019-04-04	3,058	—	$0	0	SEC↗
BALTIMORE DAVID	Director	D To issuer deriv	2019-04-02	2019-04-04	4,281	—	$0	0	SEC↗
BALTIMORE DAVID	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
BALTIMORE DAVID	Director	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
Ponoi Management, LLC	10% Owner	U Tender	2019-04-02	2019-04-02	6,642,942	$5.85	$38.86M	0	SEC↗
COLEMAN LEWIS W	Director	D To issuer	2019-04-02	2019-04-04	175,000	$5.85	$1.02M	0	SEC↗
COLEMAN LEWIS W	Director	D To issuer	2019-04-02	2019-04-04	3,000	$5.85	$17.6K	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer	2019-04-02	2019-04-04	14,620	$5.85	$85.5K	0	SEC↗
Paya Carlos V	President and CEO	D To issuer	2019-04-02	2019-04-04	35,576	$5.85	$208.1K	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer	2019-04-02	2019-04-04	37,068	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer	2019-04-02	2019-04-04	17,063	$5.85	$99.8K	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer	2019-04-02	2019-04-04	6,136	$5.85	$35.9K	0	SEC↗
BALTIMORE DAVID	Director	D To issuer	2019-04-02	2019-04-04	78,287	$5.85	$458.0K	0	SEC↗
BERGER FRANKLIN M	Director	D To issuer	2019-04-02	2019-04-04	75,000	$5.85	$438.8K	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	S Sale	2019-01-07	2019-01-07	5,516	$1.58	$8.7K	96,599	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	S Sale	2019-01-07	2019-01-07	3,522	$1.57	$5.5K	78,756	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	S Sale	2019-01-07	2019-01-07	3,414	$1.59	$5.4K	83,982	SEC↗
Paya Carlos V	President and CEO	S Sale	2019-01-07	2019-01-07	13,014	$1.58	$20.6K	156,576	SEC↗
PENHOET EDWARD	Director	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
Kelley Susan L.	Director	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
BALTIMORE DAVID	Director	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
BERGER FRANKLIN M	Director	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
COLEMAN LEWIS W	Director	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2019-01-03	2019-01-07	120,000	—	$0	120,000	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2019-01-03	2019-01-07	110,000	—	$0	110,000	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2019-01-03	2019-01-07	120,000	—	$0	120,000	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2019-01-03	2019-01-07	293,000	—	$0	293,000	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award	2019-01-03	2019-01-07	25,000	—	$0	102,115	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award	2019-01-03	2019-01-07	25,000	—	$0	82,278	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award	2019-01-03	2019-01-07	25,000	—	$0	87,396	SEC↗
Paya Carlos V	President and CEO	A Award	2019-01-03	2019-01-07	63,000	—	$0	169,590	SEC↗
Biotechnology Value Trading Fu	Other	S Sale	2018-12-04	2018-12-04	89,948	$1.83	$164.6K	370,391	SEC↗
Biotechnology Value Trading Fu	Other	S Sale	2018-12-04	2018-12-04	382,017	$1.83	$699.1K	1,942,764	SEC↗
Biotechnology Value Trading Fu	Other	S Sale	2018-12-04	2018-12-04	430,035	$1.83	$787.0K	2,502,758	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award	2018-11-07	2018-11-09	29,953	—	$0	57,278	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award	2018-11-07	2018-11-09	29,953	—	$0	77,115	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award	2018-11-07	2018-11-09	23,362	—	$0	62,396	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2018-07-17	2018-07-19	58,155	—	$0	58,155	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2018-07-17	2018-07-19	29,375	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2018-07-17	2018-07-19	417	—	$0	417	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2018-07-17	2018-07-19	625	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2018-07-17	2018-07-19	19,584	—	$0	19,584	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2018-07-17	2018-07-19	87,232	—	$0	0	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2018-07-17	2018-07-19	35,179	—	$0	35,179	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	D To issuer deriv	2018-07-17	2018-07-19	52,768	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2018-07-17	2018-07-19	5,574	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2018-07-17	2018-07-19	11,254	—	$0	11,254	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2018-07-17	2018-07-19	22,507	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2018-07-17	2018-07-19	1,247	—	$0	1,247	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2018-07-17	2018-07-19	2,493	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2018-07-17	2018-07-19	31,101	—	$0	31,101	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	D To issuer deriv	2018-07-17	2018-07-19	54,426	—	$0	0	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2018-07-17	2018-07-19	3,186	—	$0	3,186	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2018-07-17	2018-07-19	26,667	—	$0	26,667	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2018-07-17	2018-07-19	40,000	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2018-07-17	2018-07-19	4,213	—	$0	4,213	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2018-07-17	2018-07-19	8,425	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2018-07-17	2018-07-19	3,288	—	$0	3,288	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2018-07-17	2018-07-19	6,575	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2018-07-17	2018-07-19	30,911	—	$0	30,911	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2018-07-17	2018-07-19	54,094	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	D To issuer deriv	2018-07-17	2018-07-19	5,906	—	$0	0	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2018-07-17	2018-07-19	3,375	—	$0	3,375	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	1,225	—	$0	1,225	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	2,450	—	$0	0	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	48,775	—	$0	48,775	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	90,000	—	$0	0	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	60,000	—	$0	60,000	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	5,471	—	$0	0	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	3,127	—	$0	3,127	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	169,529	—	$0	0	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	8,496	—	$0	8,496	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	97,550	—	$0	0	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	44,512	—	$0	44,512	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	66,767	—	$0	0	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-07-17	2018-07-19	96,874	—	$0	96,874	SEC↗
Paya Carlos V	President and CEO	D To issuer deriv	2018-07-17	2018-07-19	12,743	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	18,350	—	$0	18,350	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	12,230	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	8,154	—	$0	8,154	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	2,838	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	1,419	—	$0	1,419	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	47,162	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	23,581	—	$0	23,581	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	50,000	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	33,334	—	$0	33,334	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	5,054	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	2,888	—	$0	2,888	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	69,946	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	39,970	—	$0	39,970	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	14,216	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	9,478	—	$0	9,478	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	70,784	—	$0	0	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-07-17	2018-07-19	47,190	—	$0	47,190	SEC↗
Brady Stephen R	EVP, Strategy & Finance	D To issuer deriv	2018-07-17	2018-07-19	27,525	—	$0	0	SEC↗
GUTHART LEO	10% Owner	P Buy	2018-01-08	2018-01-10	20,000	$3.90	$78.0K	5,664,739	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	S Sale	2018-01-05	2018-01-08	675	$4.17	$2.8K	27,325	SEC↗
Brady Stephen R	EVP, Strategy & Finance	S Sale	2018-01-05	2018-01-08	3,328	$4.17	$13.9K	47,162	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	S Sale	2018-01-05	2018-01-08	1,986	$4.17	$8.3K	39,034	SEC↗
Paya Carlos V	President and CEO	S Sale	2018-01-05	2018-01-08	7,970	$4.17	$33.2K	106,590	SEC↗
Gombotz Wayne	Chief Development Officer	S Sale	2018-01-05	2018-01-08	1,986	$4.17	$8.3K	37,068	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2018-01-04	2018-01-05	110,000	—	$0	110,000	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2018-01-04	2018-01-08	100,000	—	$0	100,000	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2018-01-04	2018-01-08	90,000	—	$0	90,000	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2018-01-04	2018-01-08	216,500	—	$0	216,500	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2018-01-04	2018-01-08	80,000	—	$0	80,000	SEC↗
BALTIMORE DAVID	Director	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
Svennilson Peter	Director, 10% Owner	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
PENHOET EDWARD	Director	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
COLEMAN LEWIS W	Director	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
BERGER FRANKLIN M	Director	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
Kelley Susan L.	Director	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award	2018-01-04	2018-01-05	22,000	—	$0	28,000	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	S Sale	2018-01-04	2018-01-05	675	$4.17	$2.8K	27,325	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award	2018-01-04	2018-01-08	20,000	—	$0	50,490	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award	2018-01-04	2018-01-08	18,000	—	$0	41,020	SEC↗
Paya Carlos V	President and CEO	A Award	2018-01-04	2018-01-08	46,500	—	$0	114,560	SEC↗
Gombotz Wayne	Chief Development Officer	A Award	2018-01-04	2018-01-08	16,000	—	$0	39,054	SEC↗
COLEMAN LEWIS W	Director	P Buy	2017-11-02	2017-11-06	50,000	$4.50	$225.0K	175,000	SEC↗
GUTHART LEO	10% Owner	G Gift	2017-10-31	2017-10-31	2,500	—	$0	5,644,739	SEC↗
BERGER FRANKLIN M	Director	P Buy	2017-10-30	2017-11-01	25,000	$4.58	$114.5K	75,000	SEC↗
Svennilson Peter	Director, 10% Owner	P Buy	2017-10-27	2017-10-27	2,681,000	$4.10	$10.99M	2,681,000	SEC↗
GOEDDEL DAVID V	10% Owner	P Buy	2017-10-27	2017-10-30	2,681,000	$4.10	$10.99M	6,642,942	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-27	2017-10-31	2,439,000	$4.10	$10.00M	5,647,239	SEC↗
COLEMAN LEWIS W	Director	P Buy	2017-10-27	2017-10-31	65,000	$4.07	$264.6K	125,000	SEC↗
BERGER FRANKLIN M	Director	P Buy	2017-10-25	2017-10-26	25,000	$4.26	$106.5K	50,000	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-24	2017-10-24	10,000	$4.35	$43.5K	3,198,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-24	2017-10-24	10,000	$4.34	$43.4K	3,208,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-24	2017-10-24	20,000	$4.35	$87.0K	3,188,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-20	2017-10-24	10,000	$5.25	$52.5K	3,168,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-20	2017-10-24	10,000	$5.26	$52.6K	3,158,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-19	2017-10-20	7,656	$6.00	$45.9K	3,148,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-10-18	2017-10-20	2,344	$6.40	$15.0K	3,140,583	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-09-18	2017-09-22	10,000	$9.70	$97.0K	3,138,239	SEC↗
Gombotz Wayne	Chief Development Officer	M Exercise deriv	2017-08-01	2017-08-03	10,000	—	$0	38,715	SEC↗
Gombotz Wayne	Chief Development Officer	S Sale	2017-08-01	2017-08-03	9,253	$11.40	$105.5K	23,801	SEC↗
Gombotz Wayne	Chief Development Officer	S Sale	2017-08-01	2017-08-03	747	$11.80	$8.8K	23,054	SEC↗
Gombotz Wayne	Chief Development Officer	M Exercise	2017-08-01	2017-08-03	10,000	$1.31	$13.1K	33,054	SEC↗
COLEMAN LEWIS W	Director	P Buy	2017-07-11	2017-07-12	2,000	$9.33	$18.7K	20,000	SEC↗
COLEMAN LEWIS W	Director	P Buy	2017-07-10	2017-07-12	10,000	$9.00	$90.0K	18,000	SEC↗
COLEMAN LEWIS W	Director	P Buy	2017-07-07	2017-07-10	4,000	$9.15	$36.6K	8,000	SEC↗
COLEMAN LEWIS W	Director	P Buy	2017-07-06	2017-07-10	4,000	$9.39	$37.6K	4,000	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-05-10	2017-05-22	5,000	$6.14	$30.7K	3,128,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-05-09	2017-05-22	13,270	$6.07	$80.5K	3,116,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-05-09	2017-05-22	1,000	$6.05	$6.0K	3,123,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-05-09	2017-05-22	6,000	$6.06	$36.4K	3,122,239	SEC↗
GUTHART LEO	10% Owner	P Buy	2017-05-09	2017-05-22	4,730	$6.12	$28.9K	3,102,969	SEC↗
BERGER FRANKLIN M	Director	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2017-01-04	2017-01-06	30,000	—	$0	30,000	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2017-01-04	2017-01-06	85,000	—	$0	85,000	SEC↗
COLEMAN LEWIS W	Director	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
Svennilson Peter	Director, 10% Owner	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
Kelley Susan L.	Director	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
PENHOET EDWARD	Director	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
BALTIMORE DAVID	Director	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2017-01-04	2017-01-06	175,000	—	$0	175,000	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2017-01-04	2017-01-06	70,000	—	$0	70,000	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2017-01-04	2017-01-06	70,000	—	$0	70,000	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award	2017-01-04	2017-01-06	6,000	—	$0	6,000	SEC↗
Brady Stephen R	EVP, Strategy & Finance	S Sale	2017-01-04	2017-01-06	1,642	$5.35	$8.8K	30,490	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award	2017-01-04	2017-01-06	15,000	—	$0	32,132	SEC↗
Paya Carlos V	President and CEO	S Sale	2017-01-04	2017-01-06	3,940	$5.35	$21.1K	68,060	SEC↗
Paya Carlos V	President and CEO	A Award	2017-01-04	2017-01-06	36,000	—	$0	72,000	SEC↗
Gombotz Wayne	Chief Development Officer	A Award	2017-01-04	2017-01-06	12,000	—	$0	24,034	SEC↗
Gombotz Wayne	Chief Development Officer	S Sale	2017-01-04	2017-01-06	980	$5.35	$5.2K	23,054	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	S Sale	2017-01-04	2017-01-06	980	$5.35	$5.2K	23,020	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award	2017-01-04	2017-01-06	12,000	—	$0	24,000	SEC↗
COLEMAN LEWIS W	Director	S Sale	2016-12-22	2016-12-27	10,000	$6.20	$62.0K	40,000	SEC↗
BERGER FRANKLIN M	Director	S Sale	2016-12-16	2016-12-20	50,000	$6.55	$327.5K	25,000	SEC↗
Yurasov Sergey	Sr. VP, Clinic. Devel. & CMO	A Award deriv	2016-10-01	2016-10-04	140,000	—	$0	140,000	SEC↗
Svennilson Peter	Director, 10% Owner	P Buy	2016-09-20	2016-09-20	800,000	$6.25	$5.00M	800,000	SEC↗
COLEMAN LEWIS W	Director	P Buy	2016-09-20	2016-09-20	40,000	$6.25	$250.0K	50,000	SEC↗
Column Group II GP, LP	10% Owner	P Buy	2016-09-20	2016-09-22	800,000	$6.25	$5.00M	3,961,942	SEC↗
Brady Stephen R	EVP, Strategy & Finance	P Buy	2016-07-15	2016-07-19	1,500	$6.84	$10.3K	17,132	SEC↗
Kelley Susan L.	Director	A Award deriv	2016-06-15	2016-06-17	23,300	—	$0	23,300	SEC↗
ATWOOD BRIAN G	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
BALTIMORE DAVID	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
BERGER FRANKLIN M	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
COLEMAN LEWIS W	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
PENHOET EDWARD	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
Svennilson Peter	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2016-01-04	2016-01-06	75,000	—	$0	75,000	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2016-01-04	2016-01-06	60,000	—	$0	60,000	SEC↗
Kenney Richard T	Chief Medical Officer	A Award deriv	2016-01-04	2016-01-06	30,000	—	$0	30,000	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2016-01-04	2016-01-06	175,000	—	$0	175,000	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2016-01-04	2016-01-06	60,000	—	$0	60,000	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award	2016-01-04	2016-01-06	15,000	—	$0	15,632	SEC↗
Gombotz Wayne	Chief Development Officer	A Award	2016-01-04	2016-01-06	12,000	—	$0	12,034	SEC↗
Kenney Richard T	Chief Medical Officer	A Award	2016-01-04	2016-01-06	7,000	—	$0	7,522	SEC↗
Paya Carlos V	President and CEO	A Award	2016-01-04	2016-01-06	36,000	—	$0	36,000	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award	2016-01-04	2016-01-06	12,000	—	$0	12,000	SEC↗
Gombotz Wayne	Chief Development Officer	M Exercise deriv	2015-11-23	2015-11-24	5,000	—	$0	48,715	SEC↗
Gombotz Wayne	Chief Development Officer	S Sale	2015-11-23	2015-11-24	5,000	$20.00	$100.0K	34	SEC↗
Gombotz Wayne	Chief Development Officer	M Exercise	2015-11-23	2015-11-24	5,000	$1.31	$6.5K	5,034	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2015-10-30	2015-11-03	90,000	—	$0	90,000	SEC↗
Brady Stephen R	EVP, Strategy & Finance	A Award deriv	2015-10-30	2015-11-03	50,000	—	$0	50,000	SEC↗
Kenney Richard T	Chief Medical Officer	A Award deriv	2015-10-30	2015-11-03	40,000	—	$0	40,000	SEC↗
ter Meulen Jan Henrik	Chief Scientific Officer	A Award deriv	2015-10-30	2015-11-03	40,000	—	$0	40,000	SEC↗
Gombotz Wayne	Chief Development Officer	A Award deriv	2015-10-30	2015-11-03	40,000	—	$0	40,000	SEC↗
Gombotz Wayne	Chief Development Officer	M Exercise deriv	2015-09-14	2015-09-16	5,000	—	$0	53,715	SEC↗
Gombotz Wayne	Chief Development Officer	S Sale	2015-09-14	2015-09-16	5,000	$16.19	$81.0K	34	SEC↗
Gombotz Wayne	Chief Development Officer	M Exercise	2015-09-14	2015-09-16	5,000	$1.31	$6.5K	5,034	SEC↗
COLEMAN LEWIS W	Director	P Buy	2015-08-25	2015-08-26	3,000	$14.50	$43.5K	3,000	SEC↗
Moorin Jay	10% Owner	S Sale	2015-05-12	2015-05-13	22,607	$22.26	$503.2K	2,138,858	SEC↗
Moorin Jay	10% Owner	S Sale	2015-05-12	2015-05-13	155,000	$21.50	$3.33M	1,983,858	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-04-24	2015-04-24	25,000	$26.64	$666.0K	2,161,465	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-04-23	2015-04-24	22,643	$27.35	$619.3K	2,186,465	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-04-23	2015-04-24	10,000	$26.64	$266.4K	2,209,108	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-04-22	2015-04-24	25,249	$26.56	$670.6K	2,219,108	SEC↗
Moorin Jay	10% Owner	S Sale	2015-04-21	2015-04-21	14,167	$26.35	$373.3K	2,244,357	SEC↗
BERGER FRANKLIN M	Director	P Buy	2015-04-21	2015-04-21	25,000	$26.50	$662.5K	75,000	SEC↗
COLEMAN LEWIS W	Director	P Buy	2015-04-21	2015-04-21	10,000	$26.50	$265.0K	10,000	SEC↗
Moorin Jay	10% Owner	S Sale	2015-04-20	2015-04-21	12,792	$26.44	$338.2K	2,258,524	SEC↗
Moorin Jay	10% Owner	S Sale	2015-04-17	2015-04-21	18,861	$26.67	$503.0K	2,271,316	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-04-16	2015-04-16	100	$26.75	$2.7K	2,290,177	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-04-15	2015-04-16	39,900	$28.57	$1.14M	2,290,377	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-04-15	2015-04-16	100	$29.17	$2.9K	2,290,277	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-04-14	2015-04-16	13,814	$27.26	$376.6K	2,330,277	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-04-07	2015-04-08	3,600	$26.55	$95.6K	2,344,091	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-04-06	2015-04-08	3,895	$26.88	$104.7K	2,347,691	SEC↗
ProQuest Associates IV LLC	10% Owner	S Sale	2015-04-01	2015-04-02	14,600	$25.51	$372.4K	2,399,440	SEC↗
ProQuest Associates IV LLC	10% Owner	S Sale	2015-04-01	2015-04-02	8,035	$27.07	$217.5K	2,351,586	SEC↗
ProQuest Associates IV LLC	10% Owner	S Sale	2015-04-01	2015-04-02	39,819	$26.55	$1.06M	2,359,621	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-25	2015-03-26	4,956	$27.56	$136.6K	2,414,040	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-24	2015-03-26	13,200	$27.67	$365.2K	2,418,996	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-23	2015-03-23	5,000	$27.78	$138.9K	2,432,196	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-20	2015-03-23	8,780	$27.19	$238.7K	2,437,880	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-20	2015-03-23	200	$28.04	$5.6K	2,437,680	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-20	2015-03-23	400	$28.13	$11.3K	2,437,280	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-20	2015-03-23	84	$28.15	$2.4K	2,437,196	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-19	2015-03-23	200	$28.07	$5.6K	2,446,660	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-19	2015-03-23	29,800	$27.55	$821.0K	2,446,860	SEC↗
COLEMAN LEWIS W	Director	A Award deriv	2015-03-18	2015-03-19	23,300	—	$0	23,300	SEC↗
Moorin Jay	10% Owner	S Sale	2015-03-18	2015-03-18	100	$27.02	$2.7K	2,476,660	SEC↗
Moorin Jay	10% Owner	S Sale	2015-03-18	2015-03-18	500	$26.99	$13.5K	2,476,760	SEC↗
Moorin Jay	10% Owner	S Sale	2015-03-18	2015-03-18	100	$27.04	$2.7K	2,477,260	SEC↗
Moorin Jay	10% Owner	S Sale	2015-03-18	2015-03-18	19,300	$26.56	$512.6K	2,477,360	SEC↗
Moorin Jay	10% Owner	S Sale	2015-03-17	2015-03-18	20,000	$25.94	$518.8K	2,496,660	SEC↗
Moorin Jay	10% Owner	S Sale	2015-03-16	2015-03-18	10,309	$25.43	$262.2K	2,516,660	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-03-12	2015-03-12	94,199	$24.94	$2.35M	2,526,969	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-03-11	2015-03-12	29,000	$25.02	$725.6K	2,621,168	SEC↗
SCHREIBER ALAIN	10% Owner	S Sale	2015-03-10	2015-03-12	6,143	$24.65	$151.4K	2,650,168	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-09	2015-03-09	32,300	$25.61	$827.2K	2,656,311	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-06	2015-03-09	100	$25.02	$2.5K	2,688,611	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-06	2015-03-09	1,046	$25.00	$26.1K	2,688,711	SEC↗
ProQuest Investments IV, L.P.	10% Owner	S Sale	2015-03-05	2015-03-09	6,000	$24.65	$147.9K	2,689,757	SEC↗
Paya Carlos V	President and CEO	A Award deriv	2015-01-07	2015-01-09	100,000	—	$0	100,000	SEC↗
Rickey James Paul	VP, Finance and Administrati	A Award deriv	2015-01-07	2015-01-09	25,000	—	$0	25,000	SEC↗
RINGO WILLIAM R	Director	A Award deriv	2015-01-07	2015-01-09	9,300	—	$0	9,300	SEC↗